Blood and tissue sample study for esophagus conditions
Part of Cancer, Digestive system clinical trials.
This study collects blood and biopsy tissue from people who are having an upper endoscopy at UNC for Barrett’s esophagus or esophageal cancer. The samples help researchers build a biorepository to study these conditions and support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be able to read and understand the consent form (English)
- Be coming to UNC hospitals for a routine upper endoscopy (upper GI scope)
- Have, or have had, Barrett’s esophagus or esophageal cancer
- Be willing to provide biopsy tissue and a blood sample for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
This study collects small tissue samples from people who already need an endoscopy (EGD) and/or surgery for esophagus or stomach-related problems. The goal is to help researchers learn more about gastroesophageal cancers and related conditions.
This study focuses on people with Barrett’s esophagus who are coming in for an endoscopy check or for treatment of early surface changes. The goal is to better understand these early warning areas and how to manage them safely.
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
This study looks at how Barrett's esophagus affects your quality of life and fear of cancer. It uses new tests to better predict who might develop esophageal cancer, so you can get the right care sooner.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.